Nasal Spray

DEVICE13 trials

Sponsors

Tarsa Therapeutics, Inc., GlaxoSmithKline, State University of New York - Upstate Medical University, Marinomed Biotech AG, Larkin Community Hospital

Conditions

Acute RhinosinusitisAllergic RhinitisAllergic RhinoconjunctivitisCOVID-19COVID19, Sars-Cov-2Chronic Rhinosinusitis (CRS)Common ColdCorona Virus Disease

Phase 1

The Safety and Antibody Response of the Nasal COV2 Vaccine Against the SARS-CoV-2 Virus

CompletedNCT06851611

Rokote Laboratories Finland OyCOVID19, Sars-Cov-2

Start: 2025-01-21End: 2025-06-26Updated: 2025-12-08

Phase 2

A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women

CompletedNCT00620854

Tarsa Therapeutics, Inc.Osteoporosis

Start: 2008-02-29End: 2008-04-30Updated: 2012-02-01

Phase 3

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

WithdrawnNCT04610801

Larkin Community HospitalCovid19

Start: 2021-12-08End: 2022-08-08Updated: 2023-10-16

Phase 4

Functional Magnetic Resonance Imaging (fMRI) Study of Nasal Strips in Nasal Congestion

CompletedNCT02275364

GlaxoSmithKlineNasal Congestion

Start: 2013-08-05End: 2013-10-30Updated: 2017-08-02

Unknown Phase

A Usability Assessment of Naloxone by Community Members

CompletedNCT03309449

State University of New York - Upstate Medical UniversityDrug Overdose

Start: 2016-08-31End: 2017-03-31Updated: 2023-06-08

Demonstration of an Anti-allergic Effect in Subjects Treated With Callergin Nasal Spray in Comparison to Untreated Subjects and Subjects Treated With Vis Alpin® Alpensalz Nasal Spray, All Suffering From Grass Pollen Induced Rhinitis/Rhinoconjunctivitis

CompletedNCT04531358

Marinomed Biotech AGAllergic Rhinitis, Allergic Rhinoconjunctivitis

Start: 2020-08-04End: 2020-12-31Updated: 2021-02-21

Demonstration of a Decongestant Effect of Coldamaris Akut Compared to Saline Nasal Spray.

CompletedNCT04532762

Marinomed Biotech AGAllergic Rhinitis, Allergic Rhinoconjunctivitis

Start: 2020-08-04End: 2020-12-31Updated: 2021-02-21

Prophylactic Treatment With Carragelose Nasal Spary to Prevent SARS-CoV-2, COVID-19, Infections in Health Care Workers

CompletedNCT04681001

Marinomed Biotech AGCommon Cold, Corona Virus Disease, COVID-19 +2

Start: 2020-12-20End: 2021-08-30Updated: 2022-08-25

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing SARS-Cov-2 Viral Load.

TerminatedNCT05290987

P & B GroupSARS-CoV-2 Infection

Start: 2022-01-14End: 2022-11-08Updated: 2022-11-17

Efficacy of ADW S-100 Ionized Water Nasal Spray in Decreasing Symptoms of Allergic Rhinitis

CompletedNCT05443945

P & B GroupAllergic Rhinitis

Start: 2022-08-30End: 2023-08-14Updated: 2023-09-21

Xylitol Based Nasal Spray for COVID-19 Treatment

Xlear, IncRespiratory Viral Infection

Start: 2022-11-28End: 2024-06-30Target: 80Updated: 2022-11-23

Efficacy and Safety of New Mometasone Furoate Nasal Spray Formulation in Acute Rhinosinusitis Patients: A Randomized Clinical Trial

CompletedNCT05639959

Saffron PharmaAcute Rhinosinusitis

Start: 2022-09-10End: 2022-11-06Updated: 2022-12-07

Position-Directed Budesonide Nasal Drops for CRS-associated Olfactory Dysfunction

Not yet recruitingNCT07386873

Peking University Third HospitalChronic Rhinosinusitis (CRS), Olfactory Dysfunction

Start: 2026-09-25End: 2028-12-31Target: 78Updated: 2026-09-16

Related Papers

Decongestant Effect of “Coldamaris Akut”, a Carrageenan- and Sorbitol-Containing Nasal Spray in Seasonal Allergic Rhinitis

International Journal of General Medicine2024-11-011 citations

Carrageenan-Containing Nasal Spray Alleviates Allergic Symptoms in Participants with Grass Pollen Allergy: A Randomized, Controlled, Crossover Clinical Trial

International Journal of General Medicine2024-02-014 citations

Efficacy of a Nasal Spray Containing Iota-Carrageenan in the Postexposure Prophylaxis of COVID-19 in Hospital Personnel Dedicated to Patients Care with COVID-19 Disease

International Journal of General Medicine2021-09-3073 citations